Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Florence Cymbalista
Early Treatment With FCR Versus Watch and Wait in Patients With Stage Binet a High-Risk Chronic Lymphocytic Leukemia (CLL): A Randomized Phase 3 Trial
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Real-World Results of Ibrutinib in Relapsed/Refractory CLL in France: Early Results on a Large Series of 428 Patients
American Journal of Hematology
Hematology
Related publications
A Phase II Trial of Eltrombopag for Patients With Chronic Lymphocytic Leukaemia (CLL) and Thrombocytopenia
British Journal of Haematology
Hematology
Evaluation of Periodontal Parameters in Patients With Early Stage Chronic Lymphocytic Leukemia
Acta Stomatologica Croatica
Dentistry
Chronic Lymphocytic Leukemia: A Review of Front-Line Treatment Options, With a Focus on Elderly CLL Patients
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Invasive Nontyphoidal Salmonella Infection in a Patient With Early-Stage Chronic Lymphocytic Leukemia
Case Reports in Infectious Diseases
High Efficacy of Venetoclax Plus Obinutuzumab in Patients With Complex Karyotype (Ckt) and Chronic Lymphocytic Leukemia (Cll): A Prospective Analysis From the Cll14 Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Bendamustine (B), Followed by Obinutuzumab (G) and Venetoclax (A) in Patients With Chronic Lymphocytic Leukemia (Cll): Cll2-Bag Trial of the German CLL Study Group (Gcllsg)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Disease Burden of Chemotherapy and Chemoimmunotherapy Treatment of Chronic Lymphocytic Leukemia（CLL）Patients in China
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Watch-And-Wait Versus Surgical Resection for Patients With Rectal Cancer
The Lancet Oncology
Oncology
DNA Methylation Signatures in Chronic Lymphocytic Leukemia (CLL)
Science-Business eXchange
